These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Advantages and disadvantages of L-TAE in diagnosis and treatment of hepatocellular carcinoma].
    Author: Shimamura Y, Ishii M, Shima Y, Takenaka H, Taniguchi H, Watanabe H, Kitai S, Sugai S, Takahashi A, Kitaya T.
    Journal: Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2535-9. PubMed ID: 2843119.
    Abstract:
    Transcatheter arterial embolization using lipiodol ultra-fluid (L-TAE) is frequently used for hepatocellular carcinoma (HCC). Its advantages are: (1) Excellent therapeutic and diagnostic ability in our pathological study of 153 resected tumors. (2) Preoperatively, we can localize HCC and prevent spreading of cancer cells by manipulation at hepatectomy. (3) Postoperatively, we can detect and treat recurrence early, and we hope to prevent recurrence by repeated L-TAE. (1) Liver infarction has occurred after L-TAE, because some lipiodol flows into the portal vein. Lipiodol remains long in the infarction area and interferes with the diagnosis of HCC. (2) Liver abscess has rarely occurred. (3) Repeated L-TAE does not impair the liver function much.
    [Abstract] [Full Text] [Related] [New Search]